Day: May 21, 2025

Complement 1 Appoints Dr. Christopher Cogle as Chief Medical Officer to Lead Clinical Strategy for Innovative Cancer Lifestyle Platform

Renowned oncologist and translational researcher to spearhead medical strategy as company scales innovative lifestyle modification modelNEW YORK, May 21, 2025...

ABLi Therapeutics Announces Details of the End of Phase 2 Meeting with FDA for Evaluation of Risvodetinib as a Treatment for Parkinson’s Disease

Agency supports primary and novel secondary and exploratory endpoints proposed for Phase 3 Trial(s) Opportunity to utilize time-to-delay of levodopa/carbidopa...

Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025

BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that...

error: Content is protected !!